Login
$LXRX
$1.79 +$0.00 (0.0%) Live

$LXRX 8-K/A SEC Filings

Filed On Filing
08 May 2023 8-K/A: Submission of Matters to a Vote of Security Holders

In accordance with the voting results from our annual meeting of stockholders held on April 27, 2023, at which our board of directors recommended that stockholders vote for the option of every “1 Year” as the preferred frequency for futu...

09 Aug 2011 8-K/A: Submission of Matters to a Vote of Security Holders

In accordance with the voting results from our annual meeting of stockholders held on April 28, 2011, at which our board of directors recommended that stockholders vote for the option of every “1 Year” as the preferred frequency for futu...

16 Mar 2011 8-K/A: Financial Statements and Exhibits

On July 30, 2010, Lexicon Pharmaceuticals, Inc. (“Lexicon”) entered into an amended and restated purchase option agreement (the “Amended and Restated Purchase Option Agreement”) with Symphony Icon Holdings LLC (“Holdings”) and Symphony I...

02 Sep 2009 8-K/A: Entry into a Material Definitive Agreement

This letter agreement (“Letter Agreement”) relates to the Second Amended and Restated Collaboration and License Agreement between Genentech, Inc. and Lexicon Pharmaceuticals, Inc. effective as of November 30, 2005 (“Agreement”). All capi...

01 May 2008 8-K/A: Departure/Election of Directors or Officers; Compensation

We invite you to serve as a consultant to Lexicon Pharmaceuticals, Inc. (which, together with its subsidiaries and affiliates, is referred to as the “Company” or “Lexicon”). The purpose of this letter agreement (this “Agreement”) is to s...

01 Nov 2005 8-K/A: Results of Operations and Financial Condition

THE WOODLANDS, TEXAS, NOVEMBER 1, 2005 -- Lexicon Genetics Incorporated (Nasdaq: LEXG), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today reported financial results for the...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support